Literature DB >> 12237659

The association between maternal factors and perinatal outcomes in triplet pregnancies.

Barbara Luke1, Clark Nugent, Cosmas van de Ven, Dibe Martin, Mary Jo O'sullivan, Sandra Eardley, Frank R Witter, Jill Mauldin, Roger B Newman.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the associations between maternal factors and outcomes in triplet pregnancies. STUDY
DESIGN: This was a historic cohort study of 194 triplet pregnancies of >or=24 weeks of gestation that were delivered from 1983 through 2001 from five medical centers.
RESULTS: In analyses that were limited to pregnancies with all live-born triplets (178 pregnancies), women with a previous good outcome (>2500 g + >37 weeks of gestation) had longer gestations (+7.9 days, P =.03), better rates of fetal growth (+4.9 g/wk, P <.0001), and higher birth weights (+153 g, P <.0001). Maternal weight gains of <36 pounds by 24 weeks of gestation were associated with lower birth weights (-197 g, P <.0001), and fetal growth rates at <or=25th percentile were associated with a shorter length of gestation (-36.7 days, P <.0001).
CONCLUSION: Previous obstetric outcome and weight gain by 24 weeks of gestation were associated significantly with fetal growth rate and birth weight; fetal growth rate, in turn, was associated significantly with length of gestation.

Entities:  

Mesh:

Year:  2002        PMID: 12237659     DOI: 10.1067/mob.2002.124957

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  Birth weight in a large series of triplets.

Authors:  Diane J Lamb; Christel M Middeldorp; Catharina E M van Beijsterveldt; Jacqueline M Vink; Monique C Haak; Dorret I Boomsma
Journal:  BMC Pediatr       Date:  2011-04-01       Impact factor: 2.125

2.  A population-based study of effect of multiple birth on infant mortality in Nigeria.

Authors:  Olalekan A Uthman; Mubashir B Uthman; Ismail Yahaya
Journal:  BMC Pregnancy Childbirth       Date:  2008-09-10       Impact factor: 3.007

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.